Literature DB >> 21476913

Fibrogenesis in nonalcoholic steatohepatitis.

Samuele De Minicis1, Gianluca Svegliati-Baroni.   

Abstract

Nonalcoholic steatohepatitis includes a wide spectrum of liver injury, ranging from simple inflammation to fibrosis and cirrhosis. Whereas simple steatosis has a benign clinical course, steatohepatitis is a recognized cause of progressive liver fibrosis and can develop, in some circumstances, into cirrhosis. The main cause of fibrogenesis is represented by the activation of myofibroblastic cells, which then start to produce matrix filaments. Matrix-producing cells, although mainly constituted of hepatic stellate cells, may have a different origin in the liver. This article will provide information on the sources of matrix-producing cells and the mechanisms involved in the development of fibrogenesis, with particular attention paid to the pathophysiological implications leading from steatohepatitis to fibrosis and cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21476913     DOI: 10.1586/egh.11.28

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  17 in total

Review 1.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

Review 2.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

3.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

Review 4.  Signal transductions and nonalcoholic fatty liver: a mini-review.

Authors:  Lu Zeng; Wai J Tang; Jin J Yin; Bei J Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 5.  Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology.

Authors:  Davide Gnocchi; Carlo Custodero; Carlo Sabbà; Antonio Mazzocca
Journal:  J Mol Med (Berl)       Date:  2019-04-05       Impact factor: 4.599

6.  Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.

Authors:  Diptadip Dattaroy; Sahar Pourhoseini; Suvarthi Das; Firas Alhasson; Ratanesh Kumar Seth; Mitzi Nagarkatti; Gregory A Michelotti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-11       Impact factor: 4.052

Review 7.  Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.

Authors:  Feng Zhang; Desong Kong; Yin Lu; Shizhong Zheng
Journal:  Cell Mol Life Sci       Date:  2012-06-15       Impact factor: 9.261

Review 8.  Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology.

Authors:  Amnon Schlegel
Journal:  Cell Mol Life Sci       Date:  2012-06-08       Impact factor: 9.261

9.  Liver fibrogenesis in non-alcoholic steatohepatitis.

Authors:  Zhaolian Bian; Xiong Ma
Journal:  Front Physiol       Date:  2012-07-11       Impact factor: 4.566

10.  Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury.

Authors:  Sihyung Wang; Ji-Seon Lee; Jeongeun Hyun; Jieun Kim; Seung U Kim; Hyuk-Jin Cha; Youngmi Jung
Journal:  Stem Cell Res Ther       Date:  2015-03-11       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.